| Identification | Back Directory | [Name]
1-arabinofuranosylcytosine-5'-stearylphosphate | [CAS]
73532-83-9 | [Synonyms]
YNK-01
Fosteabine
Stearyl-ara-CMP
Fosteabine (Cytarabine ocfosfate
Fosteabine (Synonyms: Cytarabine ocfosfate
1-arabinofuranosylcytosine-5'-stearylphosphate
2(1H)-Pyrimidinone, 4-amino-1-[5-O-[hydroxy(octadecyloxy)phosphinyl]-β-D-arabinofuranosyl]-
4-Amino-1-[5-O-[(hydroxy)(octadecyloxy)phosphinyl]-β-D-arabinofuranosyl]-1,2-dihydropyrimidin-2-one | [Molecular Formula]
C27H50N3O8P | [MDL Number]
MFCD31746875 | [MOL File]
73532-83-9.mol | [Molecular Weight]
575.68 |
| Chemical Properties | Back Directory | [Boiling point ]
711.6±70.0 °C(Predicted) | [density ]
1.28±0.1 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [solubility ]
Soluble in DMSO | [pka]
1.44±0.50(Predicted) |
| Hazard Information | Back Directory | [Uses]
Fosteabine is an oral and proagent analogue of cytarabine which is resistant to deoxycytidine deaminase. | [Definition]
ChEBI: Cytarabine ocfosfate is a pyrimidine ribonucleoside monophosphate. | [References]
[1] Maloisel F, et al. Results of a phase II trial of a combination of oral cytarabine ocfosfate (YNK01) and interferon alpha-2b for the treatment of chronic myelogenous leukemia patients in chronic phase. Leukemia. 2002 Apr;16(4):573-80. DOI:10.1038/sj.leu.2402433 |
|
| Company Name: |
NewCan Biotech Limited
|
| Telephone: |
+86-571-86912261 19975279805 |
| Website: |
https://www.newcanbio.com/ |
|